Structures by: Sasaki A.

Total: 6

Furosemide nicotinamide 1:1 cocrystal form II

C12H11ClN2O5S,C6H6N2O

Ueto, TakamitsuTakata, NoriyukiMuroyama, NorihiroNedu, AkimitsuSasaki, AkitoTanida, SatoshiTerada, Katsuhide

Crystal Growth & Design (2012) 12, 1 485

a=16.4686(4)Å   b=5.01253(14)Å   c=24.7963(7)Å

α=90°   β=108.8400(6)°   γ=90°

Furosemide nicotinamide 1:1 cocrystal form I

C12H11ClN2O5S,C6H6N2O

Ueto, TakamitsuTakata, NoriyukiMuroyama, NorihiroNedu, AkimitsuSasaki, AkitoTanida, SatoshiTerada, Katsuhide

Crystal Growth & Design (2012) 12, 1 485

a=4.86286(13)Å   b=20.7109(6)Å   c=19.3632(5)Å

α=90°   β=92.4168(6)°   γ=90°

Furosemide nicotinamide 1:1 cocrystal form III

C12H11ClN2O5S,C6H6N2O

Ueto, TakamitsuTakata, NoriyukiMuroyama, NorihiroNedu, AkimitsuSasaki, AkitoTanida, SatoshiTerada, Katsuhide

Crystal Growth & Design (2012) 12, 1 485

a=5.22828(4)Å   b=18.71272(17)Å   c=20.12138(18)Å

α=90°   β=94.8246(5)°   γ=90°

Furosemide nicotinamide 1:1 cocrystal form IV

C12H11ClN2O5S,C6H6N2O

Ueto, TakamitsuTakata, NoriyukiMuroyama, NorihiroNedu, AkimitsuSasaki, AkitoTanida, SatoshiTerada, Katsuhide

Crystal Growth & Design (2012) 12, 1 485

a=40.6357(13)Å   b=5.36051(15)Å   c=18.3727(5)Å

α=90°   β=92.5034(13)°   γ=90°

Furosemide nicotinamide 1:1 cocrystal hydrate

C12H11ClN2O5S,C6H6N2O,2(H2O)

Ueto, TakamitsuTakata, NoriyukiMuroyama, NorihiroNedu, AkimitsuSasaki, AkitoTanida, SatoshiTerada, Katsuhide

Crystal Growth & Design (2012) 12, 1 485

a=46.9784(16)Å   b=5.09800(15)Å   c=18.1866(6)Å

α=90.0000°   β=92.5680(18)°   γ=90.0000°

Kamiokite

Fe2Mo3O8

Kanazawa, Y.Sasaki, A.

Acta Crystallographica, Section C (1986) 42, 9-11

a=5.781Å   b=5.781Å   c=10.060Å

α=90°   β=90°   γ=120°